Skip to main content
. 2014 Dec;5(6):197–210. doi: 10.1177/2040620714552614

Table 2.

Histone deacetylase inhibitors (HDACis) with activity in multiple myeloma cell lines.

HDACi, Histone deacetylase inhibitor.